PhRMA Revives its Lawsuit against Enforcement of California Drug Pricing Transparency Bill SB 17

PhRMA Revives its Lawsuit against Enforcement of California Drug Pricing Transparency Bill SB 17

Source: 
FDA Law Blog
snippet: 

On September 28, 2018, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed an Amended Complaint seeking declaratory and injunctive relief against implementation and enforcement of California Senate Bill 17 (SB 17).